1. Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
- Author
-
Witte W
- Subjects
- Bacterial Toxins biosynthesis, Bacterial Typing Techniques, Cross Infection epidemiology, Cross Infection microbiology, DNA Fingerprinting, Europe epidemiology, Exotoxins biosynthesis, Genotype, Humans, Leukocidins biosynthesis, Methicillin-Resistant Staphylococcus aureus classification, Microbial Sensitivity Tests methods, North America epidemiology, Risk Factors, Virulence Factors biosynthesis, beta-Lactams pharmacology, Community-Acquired Infections epidemiology, Community-Acquired Infections microbiology, Methicillin-Resistant Staphylococcus aureus isolation & purification, Methicillin-Resistant Staphylococcus aureus pathogenicity, Staphylococcal Infections epidemiology, Staphylococcal Infections microbiology
- Abstract
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has become a matter of concern worldwide, in particular in the USA. For the analysis of emergence and spread, clear definitions based on epidemiological origin are needed for discrimination between CA-MRSA, healthcare-associated community MRSA, and healthcare-associated MRSA (HA-MRSA). Although its role in pathogenesis is currently under debate, the capability for Panton-Valentine leukocidin formation is associated with the majority of CA-MRSA isolates from North America and from Europe. Most CA-MRSA isolates are attributed to clonal lineages different from HA-MRSA; there are, however, clonal lineages from which both HA-MRSA and CA-MRSA have been reported (e.g. ST1, ST5, ST8, and ST22); CA-MRSA ST8 (USA300), which is most frequent in the USA, has meanwhile been reported from Europe. CA-MRSA ST80 is widely disseminated in Europe; because of its pronounced oxacillin heteroresistance phenotype, cefoxitin-based assays are advisable for reliable detection. So far, CA-MRSA infections seem to be much less frequent in Europe than in the USA, where patients with particular predispositions and low social status are at especial risk.
- Published
- 2009
- Full Text
- View/download PDF